Bioforce Nanosciences Holdings (BFNH) Accumulated Expenses (2020 - 2026)

Bioforce Nanosciences Holdings has disclosed Accumulated Expenses across 7 years of filings, most recently posting $607453.0 for Q1 2026.

• Quarterly Accumulated Expenses rose 17840.14% year-over-year to $607453.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $607453.0 (up 17840.14% YoY) and the FY2025 annual result came in at $506203.0, down 74.93% from the prior year.
• Accumulated Expenses advanced to $607453.0 in Q1 2026, from $506203.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $2.0 million in Q4 2024 and troughed at $3386.0 in Q1 2025.
• A 5-year average of $1.1 million and a median of $1.2 million in 2022 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2025 — Accumulated Expenses plunged 99.8% — and 2026, when it surged 17840.14%.
• Tracing BFNH's Accumulated Expenses over 5 years: stood at $1.2 million in 2022, then surged by 36.05% to $1.6 million in 2023, then rose by 26.5% to $2.0 million in 2024, then slumped by 74.93% to $506203.0 in 2025, then grew by 20.0% to $607453.0 in 2026.
• Business Quant data shows BFNH's Accumulated Expenses at $607453.0 in Q1 2026, $506203.0 in Q4 2025, and $421800.0 in Q3 2025.